3et3
From Proteopedia
| Line 1: | Line 1: | ||
| - | + | [[Image:3et3.png|left|200px]] | |
| - | [[Image:3et3. | + | |
<!-- | <!-- | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
| - | + | [[3et3]] is a 2 chain structure of [[Peroxisome Proliferator-Activated Receptors]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ET3 OCA]. | |
| + | |||
| + | ==See Also== | ||
| + | *[[Peroxisome Proliferator-Activated Receptors]] | ||
==Reference== | ==Reference== | ||
| Line 57: | Line 59: | ||
[[Category: Zinc]] | [[Category: Zinc]] | ||
[[Category: Zinc-finger]] | [[Category: Zinc-finger]] | ||
| - | |||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 18 09:06:13 2009'' | ||
Revision as of 23:46, 26 December 2010
Contents |
Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid
Template:ABSTRACT PUBMED 19116277
About this Structure
3et3 is a 2 chain structure of Peroxisome Proliferator-Activated Receptors with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Artis DR, Lin JJ, Zhang C, Wang W, Mehra U, Perreault M, Erbe D, Krupka HI, England BP, Arnold J, Plotnikov AN, Marimuthu A, Nguyen H, Will S, Signaevsky M, Kral J, Cantwell J, Settachatgull C, Yan DS, Fong D, Oh A, Shi S, Womack P, Powell B, Habets G, West BL, Zhang KY, Milburn MV, Vlasuk GP, Hirth KP, Nolop K, Bollag G, Ibrahim PN, Tobin JF. Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent. Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):262-7. Epub 2008 Dec 30. PMID:19116277
Categories: Histone acetyltransferase | Homo sapiens | Wang, W. | Zhang, K Y.J. | Activator | Acyltransferase | Adiponectin | Alternative splicing | Chromosomal rearrangement | Diabetes | Diabetes mellitus | Disease mutation | Dna-binding | Drug discovery | Fragment-based drug discovery | Metabolic disease | Metal-binding | Nucleus | Obesity | Phosphoprotein | Polymorphism | Ppar | Pparg | Ppargamma | Proto-oncogene | Receptor | Scaffold-based drug discovery | Transcription | Transcription regulation | Transferase | Ubl conjugation | Zinc | Zinc-finger
